![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 19, 2022 11:14:14 AM
CEO pointed out the opportunity on hand after carefully studying the potential REWARDS and it OUTWEIGHS the RISK him leaving a 23 Billion dollar company. He met with every BOARD MEMBER / DIRECTORS ETC ask ALLLL ??????? about the opportunities and challenges facing the company. Commercialization is a TOP Priority and he also reviewed all preclinical and clinical studies, especially MASTERS-1 in detail to the point that he took time to speak to several physicians who treat stroke and acute respiratory distress syndrome. He also spoke to several consultants regarding cell therapy space to better understand the manufacturing and regulatory challenges facing ahead in the industry. Dan did PLENTY due diligence before he CONFIRMED his INTEREST as the NEW CEO and LEADER in place. IMAGINE someone LEAVING a BILLION DOLLAR COMPANY and ACCEPTING a JOB at Athersys and the challenges ahead. Going forward with the technical / executive teams which includes several NEW members with further support commercialization plans with Healios. THE BEST IS YET TO COME ... GOOD LUCK LONGS
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM